|
Q2 2018
Filed on Aug 01, 2018
|
3,694,660
|
N/A
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
1,247,511
|
$122.75 - $141.26
$153M - $176M
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
528,207
|
$311.16 - $469.94
$164M - $248M
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
12,323
|
N/A
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
3,459,849
|
$41.74 - $48.29
$144M - $167M
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
8,800
|
N/A
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
7,150,931
|
$11.52 - $12.86
$82.4M - $92M
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
545
|
N/A
|
|
|
Q2 2018
Filed on Aug 01, 2018
|
458,172
|
N/A
|
|
|
Q1 2018
Filed on May 10, 2018
|
1,973,565
|
N/A
|
|
|
Q1 2018
Filed on May 10, 2018
|
2,275,692
|
$46.73 - $63.9
$106M - $145M
|
|
|
Q1 2018
Filed on May 10, 2018
|
8,905,329
|
N/A
|
|
|
Q1 2018
Filed on May 10, 2018
|
442,253
|
$26.7 - $30.74
$11.8M - $13.6M
|
|
|
Q1 2018
Filed on May 10, 2018
|
3,555,299
|
$28.8 - $34.4
$102M - $122M
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
4,924,863
|
$43.01 - $49.66
$212M - $245M
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
12,800
|
$30.06 - $43.61
$385K - $558K
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
3,258,698
|
$23.96 - $29.41
$78.1M - $95.8M
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
1,210,936
|
$31.66 - $38.77
$38.3M - $46.9M
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
1,143,350
|
N/A
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
10,436
|
$34.2 - $43.07
$357K - $449K
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
15,020
|
$9.64 - $14.24
$145K - $214K
|
|
|
Q4 2017
Filed on Feb 01, 2018
|
26,700
|
$80.7 - $88.58
$2.15M - $2.37M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
142,830
|
$12.65 - $18.12
$1.81M - $2.59M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
140,365
|
$5.42 - $5.86
$761K - $823K
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
4,553,544
|
$40.96 - $52.72
$187M - $240M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
15,575
|
N/A
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
1,801,105
|
$36.79 - $40.15
$66.3M - $72.3M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
10,770
|
$72.61 - $79.94
$782K - $861K
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
1,798,976
|
$65.74 - $84.83
$118M - $153M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
2,483,656
|
N/A
|
|
Keryx Biopharmaceuticals Inc
|
Q3 2017
Filed on Nov 08, 2017
|
220,600
|
N/A
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
27,460
|
$45.21 - $50.75
$1.24M - $1.39M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
72,585
|
$20.49 - $24.3
$1.49M - $1.76M
|
|
|
Q3 2017
Filed on Nov 08, 2017
|
5,614,485
|
$28.08 - $31.76
$158M - $178M
|
|